Position in TEVA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,394,839
+$113,746 QoQ
Shares Held
41,170
-3.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#300
of 673 holders
Holding Since
Mar 2023
6 quarters on record
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026IEQ CAPITAL, LLC holds $137,938,276 across 20 Drug Manufacturers - Specialty & Generic names. TEVA ranks #8 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
640,304 | $107,916,836 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
26,102 | $14,142,846 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
561,588 | $2,364,285 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
227,421 | $2,274,210 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
29,746 | $1,902,256 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
99,417 | $1,593,654 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
106,098 | $1,537,360 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
41,170 | $1,394,839 |
All Filings in TEVA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,394,839 | 41,170 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $1,281,093 | 42,533 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,305,389 | 41,826 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $719,625 | 35,625 | Shares | Other | 2025-11-14 | |
| 2023-06-30 | $756,042 | 100,404 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $885,000 | 100,000 | Shares | Sole | 2023-05-02 | |
| No filing history on record for this holder in this stock. | ||||||